Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
67.60    2.20 (3.36%)
Bid:
65.60
Ask:
70.00
Spread: 4.40 (6.707%)
Market Cap: £91.24m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMR Shareholding

7 Dec 2021 13:15

RNS Number : 8636U
Trifast PLC
07 December 2021
 

 

 

7 December 2021

 

Trifast plc

("Trifast" or the "Company")

 

Notification and public disclosure of transactions by Persons Discharging

Managerial Responsibilities and Total Voting Rights

 

Increase in PDMR shareholding

The Company announces that Ms. Clare Foster, Chief Financial Officer of the Company, a Person Discharging Managerial Responsibilities ("PDMR"), was issued and allotted a total of 35,219 ordinary shares of 5 pence each in the Company ("Ordinary Shares") on 6 December 2021 pursuant to the exercise of options under the Company's 2017 Deferred Equity Bonus Share scheme. She also completed a sale of 35,219 ordinary shares and purchase of 13,904 ordinary shares through her ISA.

 

Ms. Foster also transferred 5,562 ordinary shares to her partner's ISA.

 

Details of the transactions are shown in the PDMR notifications below.

 

Following the transactions listed above Ms. Foster and Persons Closely Associated with her remain beneficially interested in 108,352 ordinary shares of the Company.

 

Trifast plc

Lyndsey Case

Company Secretary

Tel: 44 (0) 1825 769696

www.trifast.com 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Clare Foster

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of 13,904 ordinary shares of 5p each in the Company ("Ordinary Shares") by Clare Foster through a Bed and ISA arrangement and 5,562 Ordinary Shares purchased by Clare's partner through a Bed and ISA arrangement.

c.

Price(s) and volume(s)

Transaction 1 (purchase (own ISA))

Transaction 2 (purchase (partner's ISA))

Price(s)

Volume(s)

141p

13,904

141p

5,562

d.

Aggregated information

 

Transaction 1 (purchase (own ISA))

Transaction 2 (purchase (partner's ISA))

 Price(s)

Aggregated Price

Aggregated Volume(s)

141p

£19,604.64

13,904

141p

£7,842.42

5,562

e.

Date of the transaction

3 December 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Allotment of shares pursuant to the exercise of options under the Company's 2017 Deferred Equity Bonus Share scheme

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

35,219 

d.

Aggregated information

Aggregated volume

Price

 

35,219

Nil

e.

Date of the transaction

6 December 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

6.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Sale of 35,219 ordinary shares of 5p each in the Company ("Ordinary Shares").

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

140p

35,219 

d.

Aggregated information

 

 Price(s)

Aggregated Price

Aggregated Volume(s)

140p

£49,306.60

35,219 

e.

Date of the transaction

6 December 2021

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZMGZFNFGMZM
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.